Physician profile
Mark E Angel
NPI 1154315661
$1,719.52
in general payments reported to CMS, 2019-2025
24 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $32.12 · 2021: $171 · 2022: $341 · 2023: $425 · 2024: $169 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $334.60 | 2019-2024 | Avvigo Guidance System |
| Novartis Pharmaceuticals Corporation | $267.50 | 2019-2024 | |
| Abbott Laboratories | $196.35 | 2019-2025 | Mitraclip, Dragonfly Opstar, Jot Dx |
| Medtronic, INC. | $170.03 | 2021-2023 | Onyx Frontier, Launcher |
| Janssen Pharmaceuticals, INC | $87.58 | 2019-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $70.41 | 2021-2023 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $69.51 | 2019 | |
| Biotronik INC. | $64.23 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $63.99 | 2019-2021 | |
| Abiomed | $50.79 | 2024 | Impella |
| Philips North America LLC | $44.63 | 2021-2023 | |
| Cardiva Medical, INC. | $42.04 | 2019 | |
| Amgen INC. | $39.03 | 2019-2022 | |
| Pfizer INC. | $36.41 | 2019 | |
| Cordis US Corp. | $25.14 | 2023 | Saber |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $23.94 | 2022 | |
| Atricure, INC. | $23.23 | 2023 | |
| Teleflex LLC | $20.58 | 2025 | Guideliner |
| Surmodics, INC. | $20.25 | 2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy |
| Medtronic Vascular, INC. | $18.13 | 2019 | |
| Edwards Lifesciences Corporation | $16.99 | 2022 | |
| Lundbeck LLC | $14.36 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.68 | 2019 | |
| Asahi Intecc USA, INC. | $6.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Angel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.